Investing.com -- Vir Biotechnology Inc( 纳斯达克:VIR )股价周五下跌5.6%,此前该公司宣布首席财务官Jason O’Byrne即将离职。 公司表示,高级副总裁兼首席会计官Brent ...
Chinese pharma companies are still striking global deals, but rising regulatory pressure is forcing buyers and sellers to rethink price, structure and risk ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果